Document:

exv10w17

Exhibit 10.17

STOCK OPTION AGREEMENT

To:

Grant Date:

          Pursuant to MedQuist’s Stock Option Plan (the “Plan”) adopted May 29, 2002, you are hereby
granted separate options, effective as of the grant date, to purchase that number of shares of
common stock, no par value per share (the “Common Stock”), of Medquist Inc., a New Jersey
corporation (“MedQuist”), set forth on, and at the respective, exercise prices per share indicated
on, the attached Grant Detail Report. Your option price is intended to equal at least the fair
market value of the Common Stock as of the grant date. Your right to exercise this option will
vest in equal 20% installments on each of the first 3 anniversaries of the grant date.

          This option shall terminate and is not exercisable on or after       
       (the
“Scheduled Termination Date”), except if terminated earlier as hereafter provided.

          You may exercise your option by giving written notice to the Secretary of MedQuist on forms
supplied by MedQuist at its then principal executive office, accompanied by payment of the option
price for the total number of shares you specify that you wish to purchase. The payment may be in
cash or any manner permitted under the Plan and by MedQuist.

          Your option will, to the extent not previously exercised by you, terminate ninety (90) days
after the date either (i) you cease to perform services for MedQuist or a subsidiary corporation of
MedQuist, or (ii) MedQuist or a subsidiary corporation of MedQuist delivers or receives notice of
an intention to terminate the employment relationship, regardless of whether or not a different
effective date of termination is provided in such notice, whether such termination is voluntary or
not, but not if your termination is due to disability, as defined in Section 22(e)(3) of the
Internal Revenue Code of 1986, a. amended (the “Code”), or death (but in no event later than the
Scheduled Termination date). After that date your service or employment is terminated, as
aforesaid, you may exercise this option only for the number of shares which you had a right to
purchase and did not purchase on such termination date. If you are employed by a subsidiary
corporation of MedQuist, your employment shall be deemed to have terminated on the date your
employer ceases to be a subsidiary corporation of MedQuist, unless you are on that date transferred
to MedQuist or another subsidiary corporation of MedQuist. Your employment shall not be deemed to
have terminated if you are transferred from MedQuist to a subsidiary corporation of MedQuist, or
vise versa, or from one subsidiary corporation of MedQuist to another subsidiary corporation of
MedQuist.

          If you die while employed by MedQuist or a subsidiary corporation of MedQuist, your
legatee(s), distributee(s), executor or administrator, as the case may be, may, at any time within
one year after the date of your death (but in no event later than the Scheduled Termination Date),
exercise the option as to any shares which you had a right to purchase and did not purchase during
your lifetime. It your employment by MedQuist or a subsidiary corporation of MedQuist is
terminated by reason of your becoming disabled (within the meaning of Section

 

 

22(e)(3) of the Code and the regulations thereunder), you or your legal guardian or custodian may
at any time within one year after the date of such termination (but in no event later than the
Scheduled Terminated Date), exorcise the option as to any shares which you had a right to purchase
and did not purchase prior to such termination. Your executor, administrator, guardian or
custodian must present proof of his authority satisfactory to MedQuist prior to being allowed to
exercise this option.

          In the event of any change in the outstanding shares of the Common Stock by reason of a stock
dividend, stock split, combination of shares, recapitalization, merger, consolidation, transfer of
assets, reorganization, conversion or what the Committee deems in its sole discretion to be similar
circumstances the number and kind of shares subject to this option and the option price of such
shares will be appropriately adjusted in a manner to be determined in the sole discretion of the
Committee or replaced with equal value as determined in the sole discretion of the Committee.

          The option is not transferable otherwise than by will, the laws of descent and distribution or
pursuant to a qualified domestic relations order as defined under the Internal Revenue Code of
1986, as amended, or Title I of the Employee Retirement Income Security Act, or the rules
thereunder , and is exercisable during your lifetime only by you. Until the option price has been
paid in full pursuant to due exercise of this option and the purchased shares are delivered to you,
you do not have any right, as a shareholder of MedQuist. MedQuist reserves the right not to
deliver to you the shares purchased by virtue of the exercise of this option during any period of
time in which MedQuist. deems in its sole discretion, that such delivery would violate a federal,
state, local or securities exchange rule, regulation or law or any terms of this Agreement, a prior
stock option agreement or a restrictive covenant in favor of MedQuist.

          Notwithstanding anything to the contrary contained herein, this option is not exercisable
during any period of time in which MedQuist deems that the exercisability of this option, the offer
to sell the shares options hereunder, or the sale hereof, may violate a federal, state, local or
securities exchange rule, regulation or law, or may cause MedQuist to be legally obligated to issue
or sell more shares than MedQuist is legally entitled to issue or sell.

          At the time of issuance of securities pursuant to this Plan, MedQuist may require such
restrictions, legends or other provisions as it deems necessary to comply with any federal or state
securities law.

          In the event this option is in any way inconsistent with the legal requirements of the Code or
the regulations thereunder for an “incentive stock option,” this option shall be deemed
automatically amended as of the date hereof to conform to such legal requirements, if such
conformity may be achieved by amendment. The attached Grant Detail Report specifies which of your
options are intended to be incentive stock options (if any) and which are intended to be
non-qualified stock options (if any).

          This option shall be subject to the terms of the Plan as in effect on the date this option is
granted, which terms are hereby incorporated herein by reference and made a part thereof. In the
event of any conflict between the terms of this option and the terms of the Plan, the terms of the
Plan shall govern.

2

 

          This option constitutes the entire understanding between MedQuist and you with
respect to the subject matter hereof and no amendment, modification or waiver of this
option, in whole or in part, shall be binding upon MedQuist unless in writing and
signed by a member or designee of the Compensation Committee of MedQuist.

          Your exercise will not be completed until you have paid or made suitable arrangements to pay,
(i) all federal, state and local income tax withholding required to be withheld by the Company in
connection with the option exercise and (ii) the employee’s portion of other federal, state and
local payroll and other taxes due in connection with the option exercise.

          This grant is in partial consideration of your prior execution, delivery and performance of a
Confidentiality and Non-Solicitation Agreement or similar agreement between you and MedQuist or any
of its direct or indirect subsidiaries containing confidentiality, non-solicitation or other
restrictive covenants (a “Noncompetition Agreement”). If you have not previously executed a
Noncompetition Agreement with the Company, you hereby agree to the confidentiality and
noninterference provisions set forth on Attachment A, which shall then be considered the
Noncompetition Agreement for purposes of interpreting this Agreement. If you breach the terms of
your Noncompetition Agreement, all of the options granted hereunder or granted to you previously
shall expire immediately and the grant(s) shall be deemed void. In the event of such a breach, if
you have exercised any such options within 12 months prior to or any time after the breach, you
shall be obligated to refund to MedQuist immediately an amount equal to the fair value of the
Common Stock on the date of such exercise (less the exercise price paid by you) plus subsequent
increase in value of MedQuist stock. The foregoing is separate from and in addition to any other
legal or equitable remedies to which the Company may be entitled as a result of such a breach. If
a court determines that all or a portion of your Noncompetition Agreement is not enforceable, then
this Stock Option Agreement shall be void.

          Validity, interpretation, construction, performance and enforcement of this Agreement shall be
governed by the laws of the State of New Jersey, without regard to its conflict of law principles.
The parties fully agree that the exclusive venue of any action arising out of this Agreement and
any Non-Competition Agreement shall be in the Superior Court of Burlington County, New Jersey, any
other court of the State of New Jersey having jurisdiction and value over an action arising out of
this agreement, or the United States District Court for the District of New Jersey.

          Please sign the copy of this option and return it to MedQuist’s Secretary, thereby indicating
your understanding of and agreement with its terms and conditions.

	 	 	 	 	 
	 	MEDQUIST INC. 

 	 
	(SEAL) 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 	 	(On Behalf of the Compensation Committee)  	 	 

3

 

	 	 	 	 	 

          I hereby acknowledge receipt of a copy of the foregoing stock option and, having read it
hereby signify my understanding of, and my agreement with, its terms and conditions.

	 	 	 

	 

	 	(Date)
	 
	 	 
	 

(Signature)

	 	 

4

 

ATTACHMENT A TO STOCK OPTION AGREEMENT

Confidentiality And Noninterference

     a. You covenant and agree that, in consideration of the grant to you of this stock
option, you will not, during your employment with the Company or at any tine for two (2) years
thereafter (except trade secrets shall be further protected so long as they remain trade secrets),
directly or indirectly, disclose, communicate or divulge to any individual or entity, or use for
the benefit of any individual or entity, any knowledge or information with respect to the conduct
or details of the Company’s business which you, acting reasonably, believe or should believe to be
of a confidential nature and the disclosure of which not to be in the Company’s interest. You
agree that all work performed by you for the Company is the sole property of the Company and the
Company is the sole owner of all the results and proceeds of your services for the Company.
Information of a confidential nature shall specifically include, without limitation, client lists,
pricing information, software, trade secrets, business methods and know how, employee, and
contractor lists and contact information, and information about costs, markets, sales, product and
technical and business processes.

     b. In consideration of the grant to you of this stock option, you will not, during
your employment and for a period of two (2) years thereafter, directly or indirectly, whether as an
employee, owner, partner, consultant, agent, director, officer, shareholder or in any other
capacity, engage in or be employed by any prohibited business in your territory. For purposes of
the foregoing, a prohibited business means the medical transcription processing services and
dictation business and your territory means the geographic territory in which you had business
dealings while employed by the Company. If you are a Georgia resident, the foregoing shall only
apply to the extent you perform duties and activities similar to those you performed for the
company within 100 miles of Atlanta, Georgia.

     c. You covenant and agree that, in consideration of the grant to you of this stock
option, you will not, for a period of two years after your employment with the Company ceases for
any reason whatsoever (whether voluntary or not), except with the express prior written consent of
the Company, directly or indirectly, whether as employee, owner, partner, consultant, agent,
director, officer, shareholder or in any other capacity, for your own account or for the benefit of
any individual or entity, (i) solicit any customer of the Company with whom you had dealing while
employed by the Company for business which would result in such customer terminating their
relationship with the Company, or (ii) hire or engage, or solicit or induce any individual or
entity which is an employee or contractor of the Company with whom you had dealings while employed
by the Company to leave the Company or to otherwise terminate their relationship with the Company.

     d. The parties agree that any breach by you of any of the covenants or agreements
contained in this Attachment A will result in irreparable injury to the Company for which money
damages could not adequately compensate the Company and therefore, in the event of any such breach,
the Company shall be entitled (in addition to any other rights and remedies which it may have at
law or in equity) to have an injunction issued by any competent court enjoining and restraining you
and/or any other individual or entity involved therein from continuing such

5

 

breach. The existence of any claim or cause of action which you may have against the Company or
any other individual or entity shall not constitute a defense or bar to the enforcement of such
covenants. If the Company is obliged to resort to the courts for the enforcement of any of the
covenants or agreement contained in this Attachment A or if such covenant. or agreements are
otherwise the subject of litigation between the parties, and the Company prevails in such
enforcement or litigation, then the term of such covenants and agreements shall be extended for a
period of time equal to the period of such breach, which extension shall commence on the later of
(a) the date on which the original (unextended) term of such covenants and agreements is scheduled
to terminate or (b) the date of the final court order (without further right of appeal) enforcing
such covenant or agreement.

     e. If any portion of the Covenants or agreements contained in this Attachment A,
or the application hereof, is construed to be invalid or unenforceable, the other portions of such
covenant(s) or agreement(s), or the application thereof shall not be affected and shall be given
full force and effect without regard to the invalid or enforceable portions to the fullest extant
possible. If any covenant or agreement in this Attachment A is held unenforceable because of the
area covered, the duration thereof, or the scope thereof, then the court making such determination
shall have the power to reduce the area and/or duration and/or limit the scope thereof, and the
covenant or agreement shall then be enforceable in its reduced form.

     f. For purposes of this Attachment A, the term “the Company” shall include the
Company, any successor to the Company and all present and future direct and indirect subsidiaries
and affiliates of the Company.

6exv10w18

Exhibit 10.18

MEDQUIST INC. LONG-TERM INCENTIVE PLAN

ARTICLE 1

PURPOSE OF THE PLAN

     1.1. Purpose. The purpose of the Plan is to assist the Company in attracting and
retaining key employees who are expected to contribute to the Company’s success and to achieve
long-term objectives which will inure to the benefit of all stockholders of the Company.

ARTICLE 2

DEFINITIONS

     2.1. “Award” shall mean a grant of Points to a Participant under Article 4 of the
Plan.

     2.2. “Award Agreement” shall mean any written agreement, contract or other
instrument or document evidencing any Award granted by the Committee hereunder.

     2.3. “Base Value” shall mean the Equity Value on the last day of the calendar year
immediately preceding the Performance Period.

     2.4. “Benchmark Year” shall mean the calendar year prior to the calendar year in
which vesting of Points is being assessed pursuant to Section 6.2. For purposes of determining
whether the Equity Value for a particular Benchmark Year is less than the highest Equity Value for
any Benchmark Year, calendar year 2011 shall be treated as the first Benchmark Year.

     2.5. “Board” shall mean the Board of Directors of the Company.

     2.6. “Change of Control” shall mean (1) a change in the ownership of the Company or
a change in the ownership of a substantial portion of the Company’s assets, as determined pursuant
to Exhibit A attached hereto, or (2) any other event deemed to constitute a “Change of
Control” by the Board.

     2.7. “Code” shall mean the Internal Revenue Code of 1986, as amended from time to
time, and any successor thereto.

     2.8. “Committee” shall mean the Compensation Committee of the Board (or such other
committee as may be designated by the Board).

     2.9. “Company” shall mean MedQuist Inc., a New Jersey corporation.

     2.10. “Disability” shall mean termination of a Participant’s employment for
“disability” as defined in any employment or severance agreement the Participant may have with the
Company. If no such agreement exists, “Disability” shall mean termination of a Participant’s
employment under circumstances such that the Participant (1) is unable to engage in any substantial
gainful activity by reason of any medically determinable physical or mental impairment that can be
expected to result in death or can be expected to last for a continuous

 

 

period of not less than twelve months, (2) is receiving income replacement benefits for a
period of not less than three months under an accident and health plan covering employees of the
Company, by reason of any medically determinable physical or mental impairment that can be expected
to result in death or can be expected to last for a continuous period of not less than twelve
months, or (3) has been determined to be totally disabled by the Social Security Administration.

     2.11. “EBITDA” shall mean earnings before interest, taxes, depreciation and
amortization, as adjusted pursuant to Section 8.1.

     2.12. “Equity Value” as of any date shall mean, unless otherwise determined by the
Committee, latest 12-month EBITDA times a multiple to be determined by the Committee less short and
long-term debt, plus cash, as adjusted pursuant to Section 8.1.

     2.13. “Equity Value Appreciation” shall mean the difference between the Equity Value
as of the end of the Performance Period and the Base Value.

     2.14. “Participant” shall mean an executive or key employee who is selected by the
Committee to receive an Award under the Plan.

     2.15. “Performance Period” shall mean the period over which Equity Value
Appreciation with respect to an Award is measured.

     2.16. “Plan” shall mean the MedQuist Inc. Long-Term Incentive Plan, as amended or
restated from time to time.

     2.17. “Point” shall represent an interest in the Equity Value Appreciation that may
be granted to Participants under the Plan.

     2.18. “Point Value” with respect to each Point shall mean 0.01 percent of Equity
Value Appreciation.

ARTICLE 3

ELIGIBILITY AND ADMINISTRATION

     3.1. Eligibility. Any executive or other key employee of the Company shall be
eligible to be selected as a Participant.

     3.2. Administration. The Plan shall be administered by the Committee. The Committee
shall have full power and authority, subject to the provisions of the Plan and subject to such
orders or resolutions not inconsistent with the provisions of the Plan as may from time to time be
adopted by the Board, to: (i) select the employees to whom Awards may from time to time be granted
hereunder; (ii) determine the number of Points to be covered by each Award granted hereunder;
(iii) determine the terms and conditions, not inconsistent with the provisions of the Plan, of any
Award granted hereunder; (iv) determine whether, to what extent and under what circumstances any
Award shall be canceled or suspended; (v) interpret and administer the Plan and any instrument or
agreement entered into under or in connection with the Plan, including any Award Agreement;
(vi) correct any defect, supply any omission or reconcile any

- 2 -

 

inconsistency in the Plan or any Award in the manner and to the extent that the Committee
shall deem desirable to carry it into effect; (vii) establish such rules and regulations and
appoint such agents as it shall deem appropriate for the proper administration of the Plan; and
(viii) make any other determination and take any other action that the Committee deems necessary or
desirable for administration of the Plan.

     Decisions of the Committee shall be final, conclusive and binding on all persons or
entities, including the Company, any Participant, any stockholder and any employee. A majority of
the members of the Committee may determine its actions.

     The Committee may delegate to a committee of one or more directors of the Company
or, to the extent permitted by law, to the CEO the right to grant Awards.

ARTICLE 4

GRANT OF AWARDS

     4.1. Total Number of Points. A total of 600 Points shall be authorized for grant
under the Plan during any Performance Period.

     4.2. Grant of Points. Participants (including those who become eligible to
participate in the Plan after the start of the Performance Period) may be granted Points at any
time with respect to each year in a Performance Period in the sole discretion of the Committee
based upon the performance of the Company and individual achievement. In addition, Points may be
granted in the sole discretion of the Committee at any time on or after the Effective Date to new
hires or to retain key employees. Generally the number of Points that may be granted will range
from 0 to 15 for Senior Vice Presidents (target of 10) and from 0 to 7.5 for Vice Presidents
(target of 5); provided, however, that the Committee has full discretion to grant a number of
Points above this general range to any Participant as long as the total number granted with respect
to a Performance Period does not exceed the number provided in Section 4.1. Any Award shall be
subject to the terms and conditions of the Plan and to such additional terms and conditions, not
inconsistent with the provisions of the Plan, as the Committee shall deem desirable.

     4.3. Forfeitures. If any Points are forfeited, expire or otherwise terminate without
payment, the Points shall, to the extent of such forfeiture, expiration, or termination, again be
available for Awards under the Plan.

     4.4. Award Agreements. All Awards granted shall be evidenced by an Award Agreement.

ARTICLE 5

DETERMINATION OF POINT VALUE

     5.1. Performance Period. Except as provided in Section 8.2 or otherwise determined
by the Committee, a Performance Period shall be a period of three calendar years.

- 3 -

 

     5.2. Determination of Point Value. As soon as practicable following the end of
the Performance Period and the release of the Company’s audited financials, the Committee shall
calculate the Equity Value Appreciation and Point Value for such Performance Period.

ARTICLE 6

VESTING AND PAYMENT OF AWARDS

     6.1. Vesting and Payment. Except as otherwise provided in Section 6.2 and Articles 7
and 8, Points shall vest in one-third annual increments beginning on the March 31 following the
last day of the applicable Performance Period. Each vested Point shall entitle a Participant to a
payment in cash equal to the Point Value within 60 days of the vesting date. Except as otherwise
provided in Article 7, no Participant shall be eligible for a payment unless he or she is employed
by the Company on the applicable vesting date.

     6.2. Mandatory Deferrals. Notwithstanding the provisions of Section 6.1, except as
provided in Section 7.3 and Article 8, vesting of Points with respect to a particular Performance
Period shall be deferred in any year where the Equity Value as of the most recent Benchmark Year
falls below the highest Equity Value determined for any Benchmark Year. Any such deferred Points
shall vest on the March 31 following the Benchmark Year in which the Equity Value exceeds the
highest Equity Value attained for any Benchmark Year and payment shall be made within 60 days of
the vesting date.

ARTICLE 7

TERMINATION OF EMPLOYMENT PROVISIONS

     7.1. Prior to End of Performance Period. If a Participant’s employment with the
Company terminates for any reason prior to the end of the Performance Period, all Points granted
with respect to that Performance Period shall be forfeited.

     7.2. Other than for Death or Disability following the End of the Performance Period.
If a Participant’s employment with the Company terminates for any reason other than death or
Disability after the end of the Performance Period, all unvested Points granted with respect to
that Performance Period shall be forfeited.

     7.3. Death or Disability following the End of the Performance Period. If a
Participant’s employment with the Company terminates by reason of death or a Participant suffers a
Disability following the end of the Performance Period, any unvested Points with respect to
completed Performance Periods (including those deferred pursuant to Section 6.2) shall vest and be
paid within 60 days of death or Disability.

ARTICLE 8

ADJUSTMENT AND CHANGE OF CONTROL PROVISIONS

     8.1. Adjustments. In determining EBITDA, Equity Value and Equity Value Appreciation,
the Committee may exclude the impact of an event or occurrence which the Committee determines
should appropriately be excluded, including (a) restructurings, discontinued operations,
extraordinary items, and other unusual or non-recurring charges, (b) an event either not directly
related to the operations of the Company or not within the reasonable

- 4 -

 

control of the Company’s management, or (c) a change in accounting standards required by
generally accepted accounting principles. In the event of any merger, reorganization,
consolidation, recapitalization, capital infusion, dividend or distribution (whether in cash,
shares or other property), stock split, reverse stock split, spin-off, asset purchase, asset sale,
or similar transaction or other change in corporate structure affecting the Company, the Committee
shall make such adjustments, in its sole discretion, as it deems equitable or appropriate.

     8.2. Impact of a Change of Control. Upon a Change of Control, any Awards
outstanding, including those deferred pursuant to Section 6.2, shall vest. The Point Value with
respect to Performance Periods in progress at the time of the Change of Control shall be calculated
based on the Equity Value as of the last completed quarter immediately preceding the Change of
Control minus the Base Value. Awards shall be paid within 60 days of such Change of Control.

ARTICLE 9

EFFECTIVE DATE; AMENDMENTS

     9.1. Effective Date. The Plan shall be effective as of January 1, 2009. The Plan
shall remain in effect until terminated by the Board, on which date the Plan will expire except as
to Awards then outstanding under the Plan. Such outstanding Awards shall remain in effect until
they have been settled or have expired.

     9.2. Amendment and Modification of the Plan. Subject to applicable law, the Board
may, from time to time, alter, amend, suspend or terminate the Plan as it shall deem advisable. No
amendments to, or termination of, the Plan shall in any way impair the rights of a Participant
under any Award previously granted without such Participant’s consent.

ARTICLE 10

MISCELLANEOUS

     10.1. Tax Withholding. The Company shall have the right to make all payments or
distributions pursuant to the Plan net of any applicable Federal, State and local taxes required to
be paid or withheld as a result of the settlement of an Award or any other event occurring pursuant
to the Plan. The Company shall have the right to withhold from wages or other amounts otherwise
payable such withholding taxes as may be required by law, or to otherwise require the Participant
to pay such withholding taxes. If the Participant shall fail to make such tax payments as are
required, the Company shall, to the extent permitted by law, have the right to deduct any such
taxes from any payment of any kind otherwise due to such Participant or to take such other action
as may be necessary to satisfy such withholding obligations.

     10.2. Transferability of Awards. No Award may be sold, assigned, transferred,
pledged or otherwise encumbered, other than by will or the laws of descent and distribution.

     10.3. Right of Discharge Reserved; Claims to Awards. Nothing in the Plan nor the
grant of an Award hereunder shall confer upon any employee the right to continue in the employment
or service of the Company or affect any right that the Company may have to terminate the employment
or service of (or to demote or to exclude from future Awards under the Plan) any such employee at
any time for any reason. Except as specifically provided by the

- 5 -

 

Committee, the Company shall not be liable for the loss of existing or potential profit from
an Award granted in the event of termination of an employment or other relationship. No employee or
Participant shall have any claim to be granted any Award under the Plan, and there is no obligation
for uniformity of treatment of employees or Participants under the Plan.

     10.4. Nature of Payments. All Awards made pursuant to the Plan are in consideration
of services performed or to be performed for the Company, division or business unit of the Company.
Any income or gain realized pursuant to Awards under the Plan constitute a special incentive
payment to the Participant and shall not be taken into account, to the extent permissible under
applicable law, as compensation for purposes of any of the employee benefit plans of the Company
except as may be determined by the Committee.

     10.5. Other Plans. Nothing contained in the Plan shall prevent the Board from
adopting other or additional compensation arrangements, subject to stockholder approval if such
approval is required; and such arrangements may be either generally applicable or applicable only
in specific cases.

     10.6. Severability. If any provision of the Plan shall be held unlawful or otherwise
invalid or unenforceable in whole or in part by a court of competent jurisdiction, such provision
shall (a) be deemed limited to the extent that such court of competent jurisdiction deems it
lawful, valid and/or enforceable and as so limited shall remain in full force and effect, and
(b) not affect any other provision of the Plan or part thereof, each of which shall remain in full
force and effect. If the making of any payment or the provision of any other benefit required under
the Plan shall be held unlawful or otherwise invalid or unenforceable by a court of competent
jurisdiction, such unlawfulness, invalidity or unenforceability shall not prevent any other payment
or benefit from being made or provided under the Plan, and if the making of any payment in full or
the provision of any other benefit required under the Plan in full would be unlawful or otherwise
invalid or unenforceable, then such unlawfulness, invalidity or unenforceability shall not prevent
such payment or benefit from being made or provided in part, to the extent that it would not be
unlawful, invalid or unenforceable, and the maximum payment or benefit that would not be unlawful,
invalid or unenforceable shall be made or provided under the Plan.

     10.7. Unfunded Status of the Plan. The Plan is intended to constitute an “unfunded”
plan for incentive and deferred compensation. With respect to any payments not yet made to a
Participant by the Company, nothing contained herein shall give any such Participant any rights
that are greater than those of a general creditor of the Company. In its sole discretion, the
Committee may authorize the creation of trusts or other arrangements to meet the obligations
created under the Plan; provided, however, that the existence of such trusts or other arrangements
is consistent with the unfunded status of the Plan.

     10.8. Governing Law. The Plan and all determinations made and actions taken
thereunder, to the extent not otherwise governed by the Code or the laws of the United States,
shall be governed by the laws of the State of New Jersey and construed accordingly.

- 6 -

 

     10.9. Captions. The captions in the Plan are for convenience of reference only,
and are not intended to narrow, limit or affect the substance or interpretation of the provisions
contained herein.

     10.10. Code Section 409A. All provisions of this Plan shall be interpreted in a
manner consistent with Code Section 409A’s “short-term deferral” exemption. Notwithstanding the
preceding, the Company makes no representations concerning the tax consequences of participation in
the Plan under Code Section 409A or any other federal, state, or local tax law. Tax consequences
will depend, in part, upon the application of relevant tax law, including Code Section 409A, to the
relevant facts and circumstances. Participant should consult a competent and independent tax
advisor regarding the tax consequences of this Plan.

     10.11. Clawback. Notwithstanding anything to the contrary contained herein, an Award
Agreement may provide that an Award granted thereunder shall be cancelled if the Participant,
without the consent of the Company, while employed by or providing services to the Company or after
termination of such employment or service, violates a non-competition, non-solicitation or
non-disclosure covenant or agreement or otherwise engages in activity that is in conflict with or
adverse to the interest of the Company, including fraud or conduct contributing to any financial
restatements or irregularities, as determined by the Committee in its sole discretion. The
Committee may also provide in an Award Agreement that (a) a Participant will forfeit any gain
realized on the vesting of such Award if the Participant engages in any activity referred to in the
preceding sentence, or (b) a Participant must repay the gain to the Company realized under a
previously paid Award if a financial restatement reduces the amount that would have been earned
under such Performance Award.

- 7 -

 

Exhibit A

The following rules are derived from Treasury Regulation 1.409A

-3(i)(5), and are to be construed in accordance with such regulation.

Change in the Ownership of the Company.

     A change in the ownership of the Company will occur on the date that any one person
(or more than one person acting as a group, as defined below) acquires ownership of stock of the
Company which, together with stock held by such person or group, constitutes more than 50 percent
of the total fair market value or total voting power of the stock of the Company. However, if any
one person (or more than one person acting as a group) is considered to own more than 50 percent of
the total fair market value or total voting power of the stock of the Company, the acquisition of
additional stock by the same person or persons is not considered to cause a change in the ownership
of the Company (or to cause a change in the effective control of the Company). An increase in the
percentage of stock owned by any one person (or persons acting as a group) as a result of a
transaction in which the Company acquires its stock in exchange for property will be treated as an
acquisition of stock for purposes of this provision.

Change in the Ownership of a Substantial Portion of the Assets of the Company.

     A change in the ownership of a substantial portion of the Company’s assets will
occur on the date that any one person (or more than one person acting as a group) acquires (or has
acquired during the 12-month period ending on the date of the most recent acquisition by such
person or persons) assets from the Company that have a total gross fair market value equal to or
more than 40 percent of the total gross fair market value of all of the assets of the Company
immediately before such acquisition or acquisitions. For this purpose, “gross fair market value”
means the value of the assets of the Company, or the value of the assets being disposed of,
determined without regard to any liabilities associated with such assets.

     No change in the ownership of a substantial portion of the assets of the Company
will occur as the result of a transfer of assets to an entity that is controlled by the
shareholders of the Company immediately after the transfer. A transfer of assets by the Company is
not treated as a change in the ownership of such assets if the assets are transferred to—

	 	(i)	 	A person who was a shareholder of the Company immediately before the
asset transfer, in exchange for or with respect to the Company’s
stock;
	 
	 	(ii)	 	An entity, 50 percent or more of the total value or voting power of
which is owned, directly or indirectly, by the Company;
	 
	 	(iii)	 	A person (or more than one person acting as a group) that owns,
directly or indirectly, 50 percent or more of the total value or
voting power of all the outstanding stock of the Company; or

- 8 -

 

	 	(iv)	 	An entity, at least 50 percent of the total value or
voting power of which is owned, directly or indirectly,
by a person described in the preceding clause.

For these purposes, a person’s status is generally determined immediately after the transfer of the
assets. For example, a transfer to a corporation in which the Company has no ownership interest
before the transaction but which is a majority-owned subsidiary of the Company after the
transaction is not treated as a change in the ownership of the assets of the Company.

Persons Acting As a Group

     Persons will not be considered to be acting as a group solely because they purchase
or own stock or assets of the Company at the same time, or as a result of the same public offering.
However, persons will be considered to be acting as a group if they are owners of the corporation
that enters into a merger, consolidation, purchase or acquisition of stock, or similar business
transaction with the Company. If a person (including an entity) owns stock in both the Company and
the corporation that enters into a merger, consolidation, purchase or acquisition of stock, or
similar transaction with the Company, such shareholder will be considered to be acting as a group
with other shareholders only with respect to the ownership in the Company before the transaction
giving rise to the change, and not with respect to the ownership interest in the other corporation.

Attribution of Stock Ownership.

     For purposes of the change-of-control rules set forth in this exhibit, Section
318(a) of the Internal Revenue Code applies to determine stock ownership.

- 9 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00181-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00181-of-00352.parquet"}]]